BioStem Technologies, Inc. — insider transactions

18 transactions on record · BSEM · CIK 1658678

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
18
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
9
Bought, 3m
$0
Sold, 3m
$1M
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$500K
2026-10-07
Director share, 12m
77.8%
of transactions where role is stated
Current run
18 sells
consecutive same-direction transactions
Net 3m flow
-$1M
purchases minus sales
Total on record
18

Transactions

18 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-10-092026-10-072Matuszewski JasonDirector, Chief Executive Officer, 10% OwnerExercise of derivative250,000$0.00—filing
2026-10-092026-10-072SMITH-VAN VURST ANDREWDirector, Chief Operating Officer, 10% OwnerExercise of derivative250,000$2.00$500Kfiling
2026-10-092026-10-072Matuszewski JasonDirector, Chief Executive Officer, 10% OwnerExercise of derivative250,000$2.00$500Kfiling
2026-10-092026-10-072SMITH-VAN VURST ANDREWDirector, Chief Operating Officer, 10% OwnerExercise of derivative250,000$0.00—filing
2026-08-282026-08-271Glickman Mark ADirectorExercise of derivative7,671$0.00—filing
2026-08-282026-08-271SONENREICH STEVEN DDirectorExercise of derivative7,671$0.00—filing
2026-08-282026-08-271Glickman Mark ADirectorExercise of derivative7,671$0.00—filing
2026-08-282026-08-271LESSER HANNAWAY RAYNADirectorExercise of derivative7,671$0.00—filing
2026-08-282026-08-271UNGRODT JODIDirectorExercise of derivative5,647$0.00—filing
2026-08-282026-08-271LESSER HANNAWAY RAYNADirectorExercise of derivative7,671$0.00—filing
2026-08-282026-08-271WARRINGTON KENNETH HOWARD JRDirectorExercise of derivative5,094$0.00—filing
2026-08-282026-08-271WARRINGTON KENNETH HOWARD JRDirectorExercise of derivative5,094$0.00—filing
2026-08-282026-08-271SONENREICH STEVEN DDirectorExercise of derivative7,671$0.00—filing
2026-08-282026-08-271UNGRODT JODIDirectorExercise of derivative5,647$0.00—filing
2026-08-202026-08-119POE BRANDONChief Financial OfficerExercise of derivative10,634$0.00—filing
2026-08-202026-08-0911FORTUNATO MICHAEL AChief Accounting OfficerExercise of derivative970$0.00—filing
2026-08-202026-08-0911FORTUNATO MICHAEL AChief Accounting OfficerExercise of derivative970$0.00—filing
2026-08-202026-08-119POE BRANDONChief Financial OfficerExercise of derivative10,634$0.00—filing

Source: U.S. Securities and Exchange Commission, EDGAR

BioStem Technologies, Inc. insider transactions — 18 filings on record — investment.com